CRP and rheumatoid arthritis: In this large EWAS of MTX response in RA, four DMPs that predicted an improvement of SJC and CRP at 6 months were identified in samples taken as early as 4 weeks from RA patients commencing MTX for the first time who were either extremely good or extremely poor responders by 6 months.